Aptus亏损管理股票主动型ETF ADME 深 沪
等待开盘 10-15 09:30:00 美东时间
56.2911
-0.765
-1.34%
华盛通- 最 高56.6595
- 今 开56.59
- 成交量 8518股
- 最 低 56.204
- 昨 收 57.0559
- 总市值 3.09亿
- 52周最高 57.42
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 48.1454
- 委 比 0.00%
- 总股本 549.18万
- 历史最高 57.42
- 量 比 1.21
- 振 幅 0.80%
- 历史最低 21.7898
- 每 手 1
- 风险率 2.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Mirum Advances MRM-3379 With Completed Phase 1 ADME Study
Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical stu...
10-08 00:30
Aptus Drawdown Managed Equity ETF declares $0.0416 dividend
Aptus Drawdown Managed Equity ETF (ADME) declares $0.0416/share quarterly dividend. Payable Sept. 30; for shareholders of record Sept. 29; ex-div Sept. 29. See ADME Dividend Scorecard, Yield Chart, & ...
09-30 05:27
Simulations Plus expands FDA partnership with ADMET predictor software deal
Simulations Plus (SLP) Thursday said that the U.S. Food and Drug Administration’s Cosmetics Regulatory Science Branch has licensed ADMET Predictor to support its computational research for modern cosm...
09-18 12:48
美迪西新注册《MedSDD·AI ADMET预测软件V1.0》项目的软件著作权
证券之星消息，近日美迪西（688202）新注册了《MedSDD·AI ADMET预测软件V1.0》项目的软件著作权。今年以来美迪西新注册软件著作权2个。
08-11 02:22
港股概念追踪 | 合作密集落地+巨头扎堆进场！AI制药商业化驶入快车道(附概念股)
高盛研究报告指出，AI可以将药物上市时间缩短约20%到25%，将研发过程缩短约3年，有望将整体开发成本降低约25%至30%。
07-16 07:26
Rakovina Therapeutics announces $1.5M non‑brokered private placement
Rakovina Therapeutics (RKV:CA) on Wednesday announced a non-brokered private placement offering of up to $1.5M. Rakovina will issue up to 15M equity units at an offering price of $0.10 per unit, with ...
07-16 04:47
AstraZeneca’s AZD1390 ADME Study Lays Groundwork for Future Oncology Upside
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. ...
06-13 00:33
PAVmed Q1 2026 Earnings Call Transcript
PAVmed (NASDAQ:PAVM) reported first-quarter financial results on Friday. The tr...
05-15 22:11
Adamas Trust Reports Q1 2026 Results: Full Earnings Call Transcript
Adamas Trust (NASDAQ:ADAM) held its first-quarter earnings conference call on T...
04-30 21:55
Lantern Pharma Plans First Public Demonstration Of withZeta.ai, Its Multi-Agentic AI Co-Scientist Platform On April 30
The event follows the platform's scientific community debut at the American Association for Cancer Research (AACR) Annual Meeting 2026 and its initial unveiling at Nasdaq MarketSite — and marks the first time the
04-24 19:53
